Maze Therapeutics, Inc.
MAZE
$14.49
$1.188.87%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 264.54M | 294.37M | 196.81M | 149.61M | 175.07M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 6.61M | 5.33M | 4.86M | 4.25M | 4.33M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | 100.00K | -- |
Total Current Assets | 271.15M | 299.71M | 201.67M | 153.96M | 179.40M |
|
|||||
Total Current Assets | 271.15M | 299.71M | 201.67M | 153.96M | 179.40M |
Net Property, Plant & Equipment | 27.71M | 28.80M | 29.92M | 30.93M | 32.17M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.66M | 4.34M | 8.95M | 7.59M | 4.23M |
Total Assets | 303.52M | 332.84M | 240.54M | 192.48M | 215.79M |
|
|||||
Total Accounts Payable | 3.67M | 2.40M | 1.94M | 1.02M | 2.18M |
Total Accrued Expenses | 11.52M | 11.54M | 14.10M | 11.70M | 10.62M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.72M | 4.67M | 4.63M | 4.62M | 4.57M |
Total Finance Division Other Current Liabilities | -- | -- | -- | 217.00K | 4.23M |
Total Other Current Liabilities | -- | -- | -- | 217.00K | 4.23M |
Total Current Liabilities | 19.90M | 18.62M | 20.67M | 17.56M | 21.61M |
|
|||||
Total Current Liabilities | 19.90M | 18.62M | 20.67M | 17.56M | 21.61M |
Long-Term Debt | -- | -- | -- | 51.75M | 49.10M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 20.29M | 21.15M | 22.00M | 22.80M | 23.56M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.09M | 1.01M | 969.00K | 1.01M | -- |
Total Liabilities | 41.28M | 40.77M | 43.64M | 93.11M | 94.27M |
|
|||||
Common Stock & APIC | 687.13M | 683.28M | 47.24M | 29.34M | 26.75M |
Retained Earnings | -424.89M | -391.21M | -358.43M | -313.88M | -289.12M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 262.24M | 292.07M | -311.18M | -284.53M | -262.37M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | 508.09M | 383.90M | 383.90M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | 508.09M | 383.90M | 383.90M |
|
|||||
Total Common Equity | 262.24M | 292.07M | -311.18M | -284.53M | -262.37M |
Total Preferred Equity | -- | -- | 508.09M | 383.90M | 383.90M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 262.24M | 292.07M | 196.90M | 99.37M | 121.53M |
|